Mom Raises $10k to Create Inclusive Playground for Daughter with Spina Bifida
https://pixabay.com/photos/swing-playground-children-playing-1188132/

Mom Raises $10k to Create Inclusive Playground for Daughter with Spina Bifida

Dayton Abbott is like many kindergarteners; she loves to tell jokes, play games, and hang out with friends during recess. But her playground at Alexander Elementary School wasn't built for…

Continue Reading Mom Raises $10k to Create Inclusive Playground for Daughter with Spina Bifida
Overview of Coping Mechanisms That Can Help with Isolation-Induced Depression
source: pixabay.com

Overview of Coping Mechanisms That Can Help with Isolation-Induced Depression

by Caitlin Seida from In The Cloud Copy Isolation as a result of COVID-19 precautions is necessary but can take its toll on your physical, mental, emotional, and spiritual well-being.…

Continue Reading Overview of Coping Mechanisms That Can Help with Isolation-Induced Depression
Can Wnt Activation Treat Aggressive Medulloblastoma Subtypes?
source: pixabay.com

Can Wnt Activation Treat Aggressive Medulloblastoma Subtypes?

According to Genetic Engineering & Biotechnology News, researchers recently discovered a potential therapy for patients with aggressive subtypes of medulloblastoma. There are four subtypes of this condition. The first is…

Continue Reading Can Wnt Activation Treat Aggressive Medulloblastoma Subtypes?
CUTX-101 Shows Promise for Menkes Disease
https://pixabay.com/en/copper-scrap-metal-scrap-disposal-1504098/

CUTX-101 Shows Promise for Menkes Disease

Recently, biopharmaceutical company Fortress Biotech announced positive clinical results for CUTX-101 (copper histidinate). The data highlights the efficacy of CUTX-101 for patients with Menkes disease. As there are currently no…

Continue Reading CUTX-101 Shows Promise for Menkes Disease
Severe Aplastic Anemia Patients’ Response Rates Improved with a New Triple Therapy
source: pixabay.com

Severe Aplastic Anemia Patients’ Response Rates Improved with a New Triple Therapy

  Phase III clinical trial results of the triple therapy combination for the treatment of severe aplastic anemia (SAA) were set forth in a recent News Medical Life Sciences article.…

Continue Reading Severe Aplastic Anemia Patients’ Response Rates Improved with a New Triple Therapy

Researchers Are Investigating a Possible Connection Between Chronic Fatigue Syndrome and COVID-19

Business Insider recently interviewed Marissa Oliver, a resident of New York City, who told us about the problems she has encountered during her recovery from COVID-19. Marissa, an arts manager,…

Continue Reading Researchers Are Investigating a Possible Connection Between Chronic Fatigue Syndrome and COVID-19

One Answer to the Organ Donor Shortage:  A Drug That Revitalizes Older Cells

A growing wait list is creating additional stress on patients needing organ transplants. These patients are increasingly desperate according to an article recently published in Genetic Engineering & Biotechnology News.…

Continue Reading One Answer to the Organ Donor Shortage:  A Drug That Revitalizes Older Cells

Early Stages of Precision Medicine Being Developed for Cancer Patients During the COVID-19 Pandemic

A recent article in Med City News outlines the difficult choices patients must make regarding immune compromising but life-saving therapy during the 2020 pandemic. Do they postpone their treatment or…

Continue Reading Early Stages of Precision Medicine Being Developed for Cancer Patients During the COVID-19 Pandemic

 Researchers Are Studying the Use of THC For the Treatment of ARDS caused by COVID-19

According to a recent article in Genetic Engineering & Biotechnology News, researchers at the UofSC have presented data stating that the cannabis compound tetrahydrocannabinol (THC) is effective against respiratory distress syndrome…

Continue Reading  Researchers Are Studying the Use of THC For the Treatment of ARDS caused by COVID-19

Grant Goes to Elixiron Immunotherapeutics for Alzheimer’s Disease Treatment

According to an article from Newswire, the Alzheimer's Association is awarding Elixiron Immunotherapeutics one million dollars for work on their Alzheimer's treatment, EI1071. This money will go towards a clinical…

Continue Reading Grant Goes to Elixiron Immunotherapeutics for Alzheimer’s Disease Treatment

Joint Efforts by Korean and California Research Teams Develop A Drug That Restores Renal Intervascular Cell Function

A recent article in the Korea Biomed Review reported that the joint research effort by Seoul National Medical College and Helixmith of San Diego, California, found Helixmith’s VM507 antibody effective…

Continue Reading Joint Efforts by Korean and California Research Teams Develop A Drug That Restores Renal Intervascular Cell Function
Charcot-Marie-Tooth Disease Type 1A: Experimental Three Part Therapy Shows Potential
source: pixabay.com

Charcot-Marie-Tooth Disease Type 1A: Experimental Three Part Therapy Shows Potential

According to a story from Charcot-Marie-Tooth News, a recent study suggests that the three components of the investigational therapy PXT3003 work in synergy to improve the condition of patients with…

Continue Reading Charcot-Marie-Tooth Disease Type 1A: Experimental Three Part Therapy Shows Potential
Close Menu